| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-46 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-46 |
| filingDate |
1995-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d34484fa02eab8659360e74c3eff2392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a84c8b4fdb62e3dedfafc0ed39e056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1320c20f425e89ce1898b72be2a280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_180f1f12665f2134fc934f09893f7749
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e02664d6336c339aee724156b78d9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce43857800081ee5eda084a55ddd2d6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22c9f0d3b848d109900f7cf1cc197582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3c33b18000610d5b53bd6191c7f664f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c281762ad2400c917213edddeee6bf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_257226b6910b3c7d22b86dc3b1c79447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ae6c32b758521f48b17e7eb41c19b0 |
| publicationDate |
1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5773468-A |
| titleOfInvention |
Irreversible HIV protease inhibitor having an anti-aids activity and process for the preparation thereof |
| abstract |
The present invention relates to a novel compound of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof which is an irreversible HIV protease inhibitor; a process for the preparation thereof; and a pharmaceutical composition containing the compound as an active ingredient which is useful for treating or preventing diseases caused by HIV infection. ##STR1## |
| priorityDate |
1993-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |